Holt Adrian James
Known title: SVP, Chf HR OfcrCIK: 0001977296
Associated companies
Transaction History
| EMN | ▼ Sell | Open Market | 3,283 | $234K | 8/4/2026 | View on chart |
| EMN | ▲ Buy | Grant | 4,341 | — | 6/1/2026 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 1,058 | $80K | 6/1/2026 | View on chart |
| EMN | ▼ Sell | Open Market | 1,709 | $132K | 5/5/2026 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 588 | $47K | 2/18/2026 | View on chart |
| EMN | ▲ Buy | Grant | 2,297 | $0 | 2/11/2026 | View on chart |
| EMN | ▼ Sell | Open Market | 2,037 | $206K | 2/20/2025 | View on chart |
| EMN | ▲ Buy | Grant | 2,734 | $0 | 2/18/2025 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 697 | $72K | 2/18/2025 | View on chart |
| EMN | ▼ Sell | Open Market | 3,683 | $386K | 12/3/2024 | View on chart |
| EMN | ▲ Buy | Option Exercise | 4,869 | — | 12/2/2024 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 1,186 | $124K | 12/2/2024 | View on chart |
| EMN | ▲ Buy | Option Exercise | 1,975 | $154K | 6/3/2024 | View on chart |
| EMN | ▼ Sell | Open Market | 1,975 | $196K | 6/3/2024 | View on chart |
| EMN | ▲ Buy | Option Exercise | 2,301 | $190K | 5/10/2024 | View on chart |
| EMN | ▲ Buy | Option Exercise | 1,361 | $114K | 5/10/2024 | View on chart |
| EMN | ▼ Sell | Open Market | 1,361 | $138K | 5/10/2024 | View on chart |
| EMN | ▼ Sell | Open Market | 2,301 | $233K | 5/10/2024 | View on chart |
| EMN | ▼ Sell | Open Market | 1,305 | $115K | 3/6/2024 | View on chart |
| EMN | ▲ Buy | Option Exercise | 3,430 | $250K | 3/6/2024 | View on chart |
| EMN | ▼ Sell | Open Market | 3,430 | $301K | 3/6/2024 | View on chart |
| EMN | ▲ Buy | Grant | 1,790 | $0 | 2/14/2024 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 448 | $37K | 2/14/2024 | View on chart |
| EMN | ▲ Buy | Option Exercise | 1,935 | $119K | 8/1/2023 | View on chart |
| EMN | ▼ Sell | Open Market | 1,935 | $166K | 8/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Eastman Chemical faces lower price targets from UBS, Mizuho, Citi
Three major banks recently lowered their price targets for Eastman Chemical, citing ongoing industry pressures. Despite these reductions, all firms maintained positive ratings on the stock. The company continues to offer a dividend yield of 3.86%, which remains a key feature for income-focused investors.
Eastman Chemical faces lower price targets from UBS, Mizuho, Citi. Three major banks recently lowered their price targets for Eastman Chemical, citing ongoing industry pressures. Despite these reductions, all firms maintained positive ratings on the stock. The company continues to offer a dividend yield of 3.86%, which remains a key feature for income-focused investors.